Patients with prostate cancer are at an increased risk of developing significant depression investigators highlighting a need to conduct screenin...
The FDA has granted a breakthrough device designation to the TriNetra-Prostate blood test for use in the detection of early-stage prostate cancer...
The FDA has accepted a new drug application (NDA) for the use of adagrasib (MRTX849) in the treatment of patients with non–small cell lung cancer...
The FDA has granted an orphan drug designation to the off-the-shelf natural killer (NK) cell therapy CYNK-101 as a potential treatment for patien...
Treatment with sotorasib (Lumakras) resulted in clinically meaningful responses in a population of patients with heavily pretreated KRAS G12C...
Cardiovascular ardiovascular disease (CVD) encompasses several disorders of the blood vessels and heart, including cerebrovascular, congenital he...
Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for a new monoclonal antibody for the treatment of COVID...
Treatment with cemiplimab ( Libtayo ) resulted in significantly longer survival compared with single agent chemotherapy in patients with recurr...
AstraZeneca and Merck Co.’s Lynparza may have a narrower label than GlaxoSmithKline’s rival drug Zejula in ovarian cancer, but in prostate c...
Patients with metastatic castration-resistant prostate cancer experienced an improved radiographic progression-free survival (PFS) following trea...